文献速递免疫规划传染病防控与疫情报告

3型分泌系统对假结核耶尔森菌活疫苗诱导适应性免疫和先天免疫的贡献

Contribution of the type 3 secretion system to adaptive and innate immunity induced by a live Yersinia pseudotuberculosis plague vaccine.
PubMed 文献 · Vaccine · 2025-02-19

研究比较了缺失pYV毒力质粒(编码3型分泌系统)的假结核耶尔森菌活疫苗株VpYV-与亲本株VTnF1-S。VpYV-对免疫缺陷小鼠口服不致病,单剂口服对腺鼠疫和肺鼠疫均诱导100%保护,但四个月后保护下降更多,对F1阴性菌株保护低30%,且不能诱导针对共感染耶尔森菌的即刻先天免疫保护。

要点

  • VpYV-缺失pYV质粒编码的3型分泌系统,对免疫缺陷小鼠口服不致病。
  • 单剂口服VpYV-对腺鼠疫和肺鼠疫均诱导100%保护。
  • VpYV-对F1阴性菌株保护低30%,四个月后保护下降多于VTnF1-S。

核心结论

  • VTnF1及其衍生株VpYV-提供了疫苗性能更优或安全性更高的选择,是预防和治疗健康或免疫缺陷个体鼠疫耶尔森菌感染的有用工具。

研究设计与样本

  • 研究比较了缺失pYV质粒的假结核耶尔森菌活疫苗株VpYV-与亲本株VTnF1-S在小鼠模型中的免疫原性和保护效果。

主要发现

  • VpYV-对免疫缺陷小鼠口服不致病,保留对派尔集合淋巴结和肠系膜淋巴结的趋向性,极少到达脾和肝。
  • 与VTnF1-S相比,VpYV-诱导针对F1抗原的IgG产量相当,但针对其他耶尔森菌抗原的IgG较少。
  • 单剂口服VpYV-对腺鼠疫和肺鼠疫均诱导100%保护。
  • 接种四个月后,VpYV-诱导的保护下降多于VTnF1-S。
  • VpYV-对F1阴性鼠疫耶尔森菌的保护低30%,表明pYV编码的3型分泌系统组分对获得广谱保护是必需的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Yersinia pestis, the causative agent of plague, remains a threat to public health worldwide. From the perspective of developing safe and effective vaccines, we present a derived version of our Y. pseudotuberculosis VTnF1 live attenuated vaccine candidate that lacks the pYV virulence plasmid coding for the Type 3 Secretion system (T3SS) and carries no antibiotic resistance cassettes (VTnF1-S). This strain, named VpYV-, fails to cause disease in immunocompromised mice when given orally, and can be considered as avirulent in such conditions. It retains a tropism for Peyer's patches and mesenteric lymph nodes, whilst rarely reaching the spleen and liver. When compared to VTnF1-S, VpYV- elicited equivalent production of IgG directed to the F1 antigen, but less IgG directed to other Yersinia antigens. A single oral dose of VpYV- induced 100 % protection against bubonic and pneumonic forms of plague. Four months after vaccination, the protection induced by VpYV- had decreased more than that induced by VTnF1-S. Furthermore, VpYV- was 30 % less protective against F1-negative Y. pestis, revealing that the T3SS components encoded by pYV are mandatory to obtain a large spectrum protection. Finally, VTnF1-S and VpYV- were compared for their ability to induce immediate immune activity against co-infecting Y. pestis, which could be a potential therapeutic strategy against early-stage infections. Like the historical Y. pestis vaccine EV76, VTnF1-S was able to induce such a protection. The process involved nutritional immunity in serum, indicating a fast activation of innate immune mechanisms. By contrast, VpYV- failed to protect mice, revealing an importance of the T3SS in this mechanism. Overall, VTnF1 and its derivative strain VpYV-, offer a choice between better vaccine performance or greater vaccine safety. They represent useful tools to prevent and treat Y. pestis infection in healthy or immunocompromised individuals.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Derbise A, Guillas C, Echenique-Rivera H, et al. Contribution of the type 3 secretion system to adaptive and innate immunity induced by a live Yersinia pseudotuberculosis plague vaccine. Vaccine. 2025. PMID: 39978224. doi:10.1016/j.vaccine.2025.126887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。